Send a text

Ninja Nerds!

In this episode of the Ninja Nerd Podcast, Rob and Professor Zach team up to tackle one of the most overwhelming topics in all of oncology: antineoplastic agents. This conversation is designed to turn chemo from a massive wall of disconnected drug names into a logical, pattern-based framework you can actually use on exams and on the wards.

We begin with a concise, high-yield overview of how to mentally organize chemotherapy into meaningful categories—cell–cycle–specific agents, cell–cycle–nonspecific, and miscellaneous agents. Rob and Zach lay out the big-picture logic behind each category so that when you see a drug on a vignette, you know exactly what questions to ask: What class is it in? Where does it act? What cancers depend on this pathway? And what signature toxicities should you expect?

From there, we dive into five detailed clinical cases that bring the pharmacology to life. You’ll walk through ALL induction therapy, the BEP regimen for testicular cancer, HER2-positive breast cancer treatment strategies, BCR-ABL–driven CML, and metastatic melanoma treated with immune checkpoint inhibitors. For each case, Rob challenges Zach to break down the mechanisms, indications, classic toxicity patterns, and rescue agents that students must know. Along the way, you’ll learn how to distinguish reversible versus irreversible cardiotoxicity, how to manage checkpoint inhibitor colitis, how platinums differ from alkylators, and how to decode the logic behind TKIs and immunotherapy.

The episode concludes with rapid-fire lightning rounds and a structured recap that condenses the entire world of chemotherapy into a clear, exam-ready map. By the end, you’ll understand not just what the drugs are, but how to think about them clinically—linking mechanism to tumor type to toxicity with confidence.

Whether you’re studying for USMLE, COMLEX, or PANCE, or you want a smarter way to understand cancer pharmacology, this episode will help you master the principles behind antineoplastic therapy.

Enjoy the episode and support us below!

Support the show

Send a text

Ninja Nerds!
In this episode, Rob and Zach discuss the most important clinical and pathological features of skin cancer, focusing on the three major types—basal cell carcinoma, squamous cell carcinoma, and melanoma.

We begin with basal cell carcinoma (BCC), the most common form of skin cancer, reviewing its typical appearance on sun-exposed areas, local invasiveness, and strong association with chronic UV exposure. Zach explains how to recognize key warning signs, differentiate BCC from other lesions, and understand why it rarely metastasizes despite its aggressive local behavior.

Next, we move to squamous cell carcinoma (SCC), emphasizing its connection to cumulative sun exposure, actinic keratoses, and immunosuppression. We review the classic presentation of a firm, scaly nodule or ulcer with potential for regional spread and discuss the importance of early recognition and biopsy.

The discussion concludes with a focus on melanoma, highlighting its high metastatic potential and the critical importance of early detection. We break down the ABCDE criteria for lesion evaluation, review subtypes such as superficial spreading and nodular melanoma, and explain the prognostic value of Breslow thickness in guiding management.

Each case includes the key risk factors, diagnostic findings, and treatment approaches, along with clinical pearls that reinforce the importance of prevention and early recognition. The episode ties all three cancers together into a unified framework for identifying suspicious lesions, performing timely evaluation, and improving patient outcomes.

Enjoy the episode, and please support us below!

Support the show

Send a text

Ninja Nerds!
In this episode, Rob and Zach discuss cancer screening guidelines through high-yield cases for the average-risk adult population.

We review the evidence-based recommendations for the most common malignancies, including breast, cervical, colorectal, lung, and prostate cancers, while also touching on additional screenings relevant to preventive medicine. Zach walks through each screening topic with a clear, stepwise approach that connects the pathophysiologic reasoning behind why screening matters to when it should be performed.

Each case includes the screening modality, the recommended starting and stopping ages, the screening frequency, and the key rationale behind each guideline. The discussion emphasizes how screening aims to detect disease early, reduce morbidity, and improve survival outcomes while minimizing unnecessary interventions.

This episode consolidates the essential cancer screening guidelines into a structured and practical framework, making it easy to apply in both exam preparation and clinical practice.

Enjoy the episode, and please support us below!

Support the show